Comparison between atosiban and nicardipine in inducing hypotension during in-utero transfers for threatening premature delivery.

Despite the notion that oxytocin antagonist atosiban has limited or no systemic adverse effects, these results suggest that this cost-consuming drug does not avoid hypotension and cannot help to reduce the level of monitoring.